Skip to main content

Table 4 Comparsion of outcome variables characterizing the measurement of the SP, SPAP variable at baseline and after application of KT between injured and healthy side in Placebo group

From: Does kinesiotaping can improve static stability of the knee after anterior cruciate ligament rupture? A randomized single-blind, placebo‐controlled trial

  Baseline Post X difference
(95 % CI)
pa ESa
X ± SD X ± SD
SP
[mm]
Placebo
injured
1073.9 ± 266.5 1033.1 ± 289.2 -40.8 (1.45 to 2.56) 0.060 0.14
Placebo
healthy
967.3 ± 219.77 934.8 ± 285.1 -32.5 (1.24 to 1.64) 0.104 0.12
pb 0.049 0.045    
  ESb 0.43 0.34    
SPAP
[mm]
Placebo
injured
702.4 ± 219.3 698.1 ± 217.5 -4.3 (1.01 to 3.01) 0.067 0.01
Placebo
healthy
625.8 ± 234.1 616.9 ± 237.6 -8.9 (1.32 to 1.84) 0.269 0.03
pb 0.027 0.018    
  ESb 0.33 0.35    
SPML
[mm]
Placebo
injured
752.1 ± 208.6 728.6 ± 194.8 -63.5 (1.26 to 2.69) 0.221 0.11
Placebo
healthy
690.4 ± 276.3 683.9 ± 230.2 -6,5 (1.23 to 1.54) 0.138 0.02
pb 0.038 0.011    
  ESb 0.25 0.23    
MV
[mm/s]
Placebo
injured
37.3 ± 9.9 35.6 ± 9.5 -1.7 (1.11 to 2.34) 0.089 0.17
Placebo
healthy
32.4 ± 5.6 31.8 ± 4.7 -0.6 (0.97 to 2.45) 0.076 0.11
pb 0.043 0.047    
ESb 0.60 0.50    
MVAP
[mm/s]
Placebo
injured
23.8 ± 7.4 22.2 ± 7.9 -1.6 (1.22 to 2.62) 0.079 0.20
Placebo
healthy
19.5 ± 5.9 18.9 ± 3.8 -0.6 (0.21 to 1.31) 0.139 0.12
pb 0.039 0.042    
ESb 0.64 0.53    
MVML
[mm/s]
Placebo
injured
25.1 ± 6.4 23.1 ± 6.2 -2 (1.29 to 2.97) 0.112 0.31
Placebo
healthy
19.9 ± 3.9 19.5 ± 4.6 -0.4 (0.34 to 2.49) 0.177 0.10
pb 0.047 0.034    
ESb 0.98 0.69    
  1. Placebo injured – injured side; Placebo healthy – healthy side